Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "almotriptan malate tablets are a 5ht 1b 1d acute treatment of migraine attacks in adults with a history of migraine with or without aura 1 1 acute treatment of migraine headache pain in adolescents age 12 to 17 years with a history of migraine with or without aura and who have migraine attacks usually lasting 4 hours or more 1 1 important limitations use only after a clear diagnosis of migraine has been established 1 2 in adolescents age 12 to 17 years efficacy of almotriptan malate tablets on migraine associated symptoms was not established 1 2 not intended for the prophylactic therapy of migraine 1 2 not indicated for the treatment of cluster headache 1 2 adults almotriptan malate tablets are indicated for the acute treatment of migraine attacks in patients with a history of migraine with or without aura adolescents age 12 to 17 years almotriptan malate tablets are indicated for the acute treatment of migraine headache pain in patients with a history of migraine attacks with or without aura usually lasting 4 hours or more when untreated almotriptan malate tablets should only be used where a clear diagnosis of migraine has been established if a patient has no response for the first migraine attack treated with almotriptan malate tablets the diagnosis of migraine should be reconsidered before almotriptan malate tablets are administered to treat any subsequent attacks in adolescents age 12 to 17 years efficacy of almotriptan malate tablets on migraine associated symptoms nausea photophobia and phonophobia was not established almotriptan malate tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine see contraindications 4 7 safety and effectiveness of almotriptan malate tablets have not been established for cluster headache which is present in an older predominantly male population" ?g. }

• association label "almotriptan malate tablets are a 5ht 1b 1d acute treatment of migraine attacks in adults with a history of migraine with or without aura 1 1 acute treatment of migraine headache pain in adolescents age 12 to 17 years with a history of migraine with or without aura and who have migraine attacks usually lasting 4 hours or more 1 1 important limitations use only after a clear diagnosis of migraine has been established 1 2 in adolescents age 12 to 17 years efficacy of almotriptan malate tablets on migraine associated symptoms was not established 1 2 not intended for the prophylactic therapy of migraine 1 2 not indicated for the treatment of cluster headache 1 2 adults almotriptan malate tablets are indicated for the acute treatment of migraine attacks in patients with a history of migraine with or without aura adolescents age 12 to 17 years almotriptan malate tablets are indicated for the acute treatment of migraine headache pain in patients with a history of migraine attacks with or without aura usually lasting 4 hours or more when untreated almotriptan malate tablets should only be used where a clear diagnosis of migraine has been established if a patient has no response for the first migraine attack treated with almotriptan malate tablets the diagnosis of migraine should be reconsidered before almotriptan malate tablets are administered to treat any subsequent attacks in adolescents age 12 to 17 years efficacy of almotriptan malate tablets on migraine associated symptoms nausea photophobia and phonophobia was not established almotriptan malate tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine see contraindications 4 7 safety and effectiveness of almotriptan malate tablets have not been established for cluster headache which is present in an older predominantly male population" assertion.